Telomir Pharmaceuticals, Inc. Long-term Debt, Gross
Telomir Pharmaceuticals, Inc. (TELO) had Long-term Debt, Gross of $100.00 thousand as of 2024-12-31, per its 10-K filed 2025-02-04.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2025-02-04
- 2024-12-31: Long-term Debt, Gross $100.00K.
- 2024-09-30: Long-term Debt, Gross $100.00K.
- 2024-06-30: Long-term Debt, Gross $140.00K.
- 2024-03-31: Long-term Debt, Gross $8.00K.
| Period end | Long-term Debt, Gross |
|---|---|
| 2024-12-31 | $100.00K 10-K · filed 2025-02-04 |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $140.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $8.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $500.00K 10-K · filed 2025-02-04 |
| 2022-12-31 | $600.00K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |